AP ACTIMIS PHARMACEUTICALS Trademark

Trademark Overview

On Tuesday, April 4, 2006, a trademark application was filed for AP ACTIMIS PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the AP ACTIMIS PHARMACEUTICALS trademark a serial number of 78853453. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 1, 2019. This trademark is owned by Actimis Pharmaceuticals, Inc.. The AP ACTIMIS PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, technological and development services, namely, pharmaceutical research and pharmaceutical drug development services for applying proprietary chemical technologies and analysis to pharmaceutical drug discovery processes and research, identifying novel drug targets and biomarkers, selectively profiling drug candidates in biological samples, characterizing target activities of drug candidates and established drugs to understand the basis for their efficacy and toxicity, and monitoring clinical trials in the field of respiratory, anti-inflammatory and auto-immunity disorders; laboratory research in the field of respiratory, anti-inflammatory and auto-immunity disorders
ap actimis pharmaceuticals

General Information

Serial Number78853453
Word MarkAP ACTIMIS PHARMACEUTICALS
Filing DateTuesday, April 4, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 1, 2019
Registration Number3600352
Registration DateTuesday, March 31, 2009
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 21, 2006

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesScientific research, technological and development services, namely, pharmaceutical research and pharmaceutical drug development services for applying proprietary chemical technologies and analysis to pharmaceutical drug discovery processes and research, identifying novel drug targets and biomarkers, selectively profiling drug candidates in biological samples, characterizing target activities of drug candidates and established drugs to understand the basis for their efficacy and toxicity, and monitoring clinical trials in the field of respiratory, anti-inflammatory and auto-immunity disorders; laboratory research in the field of respiratory, anti-inflammatory and auto-immunity disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 1, 2019
Primary Code042
First Use Anywhere DateFriday, December 31, 2004
First Use In Commerce DateFriday, December 31, 2004

Trademark Owner History

Party NameActimis Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameActimis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameActimis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Friday, November 1, 2019CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, March 31, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 20, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, November 20, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 20, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 30, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 31, 2009REGISTERED-PRINCIPAL REGISTER
Friday, February 20, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, February 20, 2009ASSIGNED TO LIE
Thursday, February 12, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 11, 2009STATEMENT OF USE PROCESSING COMPLETE
Monday, February 9, 2009USE AMENDMENT FILED
Monday, February 9, 2009TEAS STATEMENT OF USE RECEIVED
Thursday, August 21, 2008EXTENSION 3 GRANTED
Tuesday, August 12, 2008EXTENSION 3 FILED
Thursday, August 21, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 12, 2008TEAS EXTENSION RECEIVED
Thursday, February 28, 2008EXTENSION 2 GRANTED
Sunday, February 10, 2008EXTENSION 2 FILED
Sunday, February 10, 2008TEAS EXTENSION RECEIVED
Monday, September 17, 2007EXTENSION 1 GRANTED
Monday, August 13, 2007EXTENSION 1 FILED
Monday, August 13, 2007TEAS EXTENSION RECEIVED
Thursday, May 31, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 31, 2007TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 13, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 21, 2006PUBLISHED FOR OPPOSITION
Wednesday, November 1, 2006NOTICE OF PUBLICATION
Friday, September 29, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 27, 2006ASSIGNED TO LIE
Tuesday, September 19, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 19, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, September 19, 2006EXAMINERS AMENDMENT E-MAILED
Tuesday, September 19, 2006EXAMINERS AMENDMENT -WRITTEN
Friday, September 15, 2006ASSIGNED TO EXAMINER
Monday, July 10, 2006APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 10, 2006TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 7, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals actimis drug research pharmaceutical inflammatory field candidates auto anti respiratory immunity